A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer


NCT02935634

Interventional

Phase 2

Completed
FRACTION-GC
The purpose of this study is to evaluate the preliminary efficacy, safety, and tolerability of Nivolumab in combination with Ipilimumab or other treatment therapies in participants with advanced gastric cancer.
More informations
Nov 29,2016
All
18 Years
N/A
190